Cerebras Systems Inc. (CBRS) is a Sunnyvale, California-based AI infrastructure company whose wafer-scale engine — a single chip spanning an entire silicon wafer — powers training and inference systems sold as data-center racks, alongside its own cloud inference service. The shares traded at $98.53 shortly after Wednesday's open, a decline of 5.42% from the prior session's close of $104.18, confirming a move to the downside. No verified company-specific catalyst explained the drop: there was no new release, filing, or guidance update. Instead, the selling coincided with renewed scrutiny of how far 2026's largest AI-related IPOs have fallen below their first-day trading prices, a narrative that hit the entire cohort of recently listed, high-multiple AI names.
The most credible driver of Wednesday's weakness was a familiar one for holders: the unwind of first-day enthusiasm. Commentary circulating before the open focused on the fact that the three biggest U.S. listings of 2026 — SpaceX (SPCX), SK hynix (SKHY) and Cerebras — all trade below their debut-session prices, with Cerebras and SK hynix also below their IPO prices. The framing matters more than the arithmetic: since 2008, the largest IPOs have tended to break their first-day levels within a year, often within weeks. With valuation questions swirling around Anthropic's pending listing, investors used the session to trim exposure to the same trade — expensive, newly public AI infrastructure.
The overhang from third-quarter results has not cleared. Analyst price targets were cut sharply after the Nov. 12 report, including Morgan Stanley to $178 from $279, Wedbush to $190 from $290, UBS to $155 from $250, Needham to $200 from $300 and TD Cowen to $175. Ratings were maintained at Outperform or Buy throughout, and the consensus stance remains constructive with an average target far above the current price. Even so, a cluster of reductions framed as "multiple compression across AI" gives sellers a rationale on any soft tape.
The underlying numbers explain why the stock is volatile rather than directionally clear. Third-quarter GAAP revenue rose 55% to $210.8 million, slightly below the $214.7 million consensus, while the GAAP net loss widened to $161.2 million, or $0.67 a share, and GAAP gross margin came in near 20%. Core revenue, which adjusts for stock-based compensation and customer warrants, rose 70% to a record $230.9 million and produced $29.8 million of core net income — the first positive result since listing. Cloud and services revenue more than tripled while hardware revenue declined. Management guided fourth-quarter core revenue to $310–330 million, raised full-year core revenue to $940–960 million, and projected tripling revenue in 2027, backed by $26.1 billion of remaining performance obligations, 700 megawatts of secured capacity, and new agreements with Microsoft (MSFT), Oracle (ORCL) and an unnamed top-three hyperscaler.
Turnover in Cerebras has been heavy: average daily volume runs near 9.5 million shares, with more than 21 million shares changing hands on the Nov. 13 earnings reaction. Wednesday's decline was concentrated in recently listed AI names rather than accompanied by any scheduled company event, and it followed NVIDIA (NVDA)-related leadership uncertainty that has kept AI infrastructure sentiment choppy. Technically, the stock has slipped back below the $100 handle and is retracing the rebound off the Nov. 5 low of $77.84; the Nov. 13 high of $120.44 now stands as near-term resistance, with the 52-week low of $77.84 the line that has repeatedly defined the downside.
The score runs from 0, meaning no meaningful news and a normal move for the stock, to 100, meaning transformative news and an extreme, rare move. Here it is 17 out of 100. The verified news flow was thin — no company release or filing, only sentiment pieces on IPO performance and already-published analyst target cuts, none material relative to a roughly $24 billion market capitalization. The price move was equally unremarkable: a 5.42% decline is about 1.1 times the stock's typical daily swing, and moves of that size occurred 25 times in the past 69 sessions. Weak news plus an ordinary move produces a low score.
Attention now shifts to the fourth quarter, where guidance of $310–330 million in core revenue implies roughly 39% sequential growth and management's first attempt at near-break-even core operating margins. Investors will watch whether cloud revenue — flat sequentially in the third quarter — reaccelerates as Microsoft and Oracle capacity comes online, and whether hardware sales stabilize after declining year over year. The beaten-down IPO cohort and any update on Anthropic's listing could set the tone for the whole group. Risks include customer concentration around OpenAI, conversion of the $26.1 billion backlog amid data-center power and construction delays, gross-margin pressure from the cloud build-out, and the possibility of further estimate and target revisions after a quarter that missed on GAAP revenue and earnings.
Tickeron's Trending AI Robots page offers a curated view of automated trading strategies that are outperforming in current market conditions. The platform hosts hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers make it into this featured section. Bots differ by strategy logic, holding period, performance metrics, and the symbols they trade, so visitors can compare approaches side by side. For readers tracking volatile AI names like Cerebras, reviewing the trending list is a practical next step.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 5 cases where CBRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 16, 2026. You may want to consider a long position or call options on CBRS as a result. In 11 of 11 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for CBRS just turned positive on November 09, 2026. Looking at past instances where CBRS's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.
Following a +18.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRS advanced for three days, in 17 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.327) is normal, around the industry mean (5.443). P/E Ratio (-19.264) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors